These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 18276941)

  • 1. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.
    Ohno Y; Iwasawa T; Seo JB; Koyama H; Takahashi H; Oh YM; Nishimura Y; Sugimura K
    Am J Respir Crit Care Med; 2008 May; 177(10):1095-102. PubMed ID: 18276941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Matsumoto S; Obara M; Sugimura K
    AJR Am J Roentgenol; 2008 Feb; 190(2):W93-9. PubMed ID: 18212207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of capability of dynamic O₂-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Nishimura Y; Sugimura K
    Eur J Radiol; 2012 May; 81(5):1068-75. PubMed ID: 21392914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Takahashi M; Van Cauteren M; Sugimura K
    AJR Am J Roentgenol; 2011 Aug; 197(2):W279-85. PubMed ID: 21785054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers.
    Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Seki S; Obara M; van Cauteren M; Takahashi M; Sugimura K
    J Magn Reson Imaging; 2014 Apr; 39(4):988-97. PubMed ID: 24123342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography.
    Xia Y; Guan Y; Fan L; Liu SY; Yu H; Zhao LM; Li B
    COPD; 2014 Sep; 11(5):510-20. PubMed ID: 25211632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Oxygen-Enhanced MRI at 3T MR System: Comparison With Thin-Section CT of Quantitative Capability for Pulmonary Functional Loss Assessment and Clinical Stage Classification of COPD in Smokers.
    Ohno Y; Yui M; Yoshikawa T; Seki S; Takenaka D; Kassai Y; Hattori H; Murayama K; Toyama H
    J Magn Reson Imaging; 2021 Apr; 53(4):1042-1051. PubMed ID: 33205499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D lung motion assessments on inspiratory/expiratory thin-section CT: Capability for pulmonary functional loss of smoking-related COPD in comparison with lung destruction and air trapping.
    Koyama H; Ohno Y; Fujisawa Y; Seki S; Negi N; Murakami T; Yoshikawa T; Sugihara N; Nishimura Y; Sugimura K
    Eur J Radiol; 2016 Feb; 85(2):352-9. PubMed ID: 26781140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial.
    van Beek EJ; Dahmen AM; Stavngaard T; Gast KK; Heussel CP; Krummenauer F; Schmiedeskamp J; Wild JM; Søgaard LV; Morbach AE; Schreiber LM; Kauczor HU
    Eur Respir J; 2009 Dec; 34(6):1311-21. PubMed ID: 19541712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen-enhanced MRI for patients with connective tissue diseases: comparison with thin-section CT of capability for pulmonary functional and disease severity assessment.
    Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Seki S; Tsubakimoto M; Sugimura K
    Eur J Radiol; 2014 Feb; 83(2):391-7. PubMed ID: 24355658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.
    Hueper K; Vogel-Claussen J; Parikh MA; Austin JH; Bluemke DA; Carr J; Choi J; Goldstein TA; Gomes AS; Hoffman EA; Kawut SM; Lima J; Michos ED; Post WS; Po MJ; Prince MR; Liu K; Rabinowitz D; Skrok J; Smith BM; Watson K; Yin Y; Zambeli-Ljepovic AM; Barr RG
    Am J Respir Crit Care Med; 2015 Sep; 192(5):570-80. PubMed ID: 26067761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes.
    Fan L; Xia Y; Guan Y; Zhang TF; Liu SY
    Clin Respir J; 2014 Jan; 8(1):45-54. PubMed ID: 23711228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Xenon-Enhanced Area-Detector CT and Krypton Ventilation SPECT/CT for Assessment of Pulmonary Functional Loss and Disease Severity in Smokers.
    Ohno Y; Fujisawa Y; Takenaka D; Kaminaga S; Seki S; Sugihara N; Yoshikawa T
    AJR Am J Roentgenol; 2018 Feb; 210(2):W45-W53. PubMed ID: 29220212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of pulmonary perfusion using dynamic contrast-enhanced CT in patients with chronic obstructive pulmonary disease: correlations with pulmonary function test and CT volumetric parameters.
    Guan Y; Xia Y; Fan L; Liu SY; Yu H; Li B; Zhao LM; Li B
    Acta Radiol; 2015 May; 56(5):573-80. PubMed ID: 24917608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD Patients Have Short Lung Magnetic Resonance T1 Relaxation Time.
    Alamidi DF; Morgan AR; Hubbard Cristinacce PL; Nordenmark LH; Hockings PD; Lagerstrand KM; Young SS; Naish JH; Waterton JC; Maguire NC; Olsson LE; Parker GJ
    COPD; 2016; 13(2):153-9. PubMed ID: 26488310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean bronchial wall attenuation value in chronic obstructive pulmonary disease: comparison with standard bronchial parameters and correlation with function.
    Lederlin M; Laurent F; Dromer C; Cochet H; Berger P; Montaudon M
    AJR Am J Roentgenol; 2012 Apr; 198(4):800-8. PubMed ID: 22451544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
    Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
    Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenon-enhanced CT using subtraction CT: Basic and preliminary clinical studies for comparison of its efficacy with that of dual-energy CT and ventilation SPECT/CT to assess regional ventilation and pulmonary functional loss in smokers.
    Ohno Y; Yoshikawa T; Takenaka D; Fujisawa Y; Sugihara N; Kishida Y; Seki S; Koyama H; Sugimura K
    Eur J Radiol; 2017 Jan; 86():41-51. PubMed ID: 28027764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.